1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Morten Jørgensen (Inventor), Benny Bang-Andersen (Inventor), Nicholas Moore (Inventor), André Faldt (Inventor), Arne Mørk (Inventor), Heidi Lopez De Diego (Inventor), René Holm (Inventor), Tine Bryan Stensbøl (Inventor), Lone Munch Ringgard (Inventor), Michael J Mealy (Inventor), Michael Harold Rock (Inventor), Jørgen Brodersen (Inventor)

Research output: Patent

Abstract

1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

Original languageEnglish
IPCC07D 295/ 096 A I
Patent numberUS2016083359
Country/TerritoryDenmark
Priority date23/11/2015
Priority numberUS201514948775
Publication statusPublished - 24. Mar 2016
Externally publishedYes

Fingerprint

Dive into the research topics of '1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment'. Together they form a unique fingerprint.

Cite this